Back to company

ENKAM PHARMACEUTICALS ApS: Financial statements 2017

CVR: 25812921

ENKAM PHARMACEUTICALS ApS (CVR 25812921) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -239,433 and a net result of DKK -277,379 compared with DKK -345,030 the year before. Equity amounted to DKK -885,809.

Gross Profit
-239,433 kr.
Profit/Loss
-277,379 kr.
Equity
-885,809 kr.
Total Assets
20,914 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017--239 t.-277 t.-886 t.0
2016--272 t.-345 t.-608 t.0
2015--426 t.-488 t.-263 t.-
2014-4.7 mio.2.8 mio.-1.9 mio.-
2013--2.6 mio.-3.7 mio.-4.7 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ENKAM PHARMACEUTICALS ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

ENKAM PHARMACEUTICALS ApS: The 2016 annual report is outJun 5, 2017

ENKAM PHARMACEUTICALS ApS has published its annual report for 2016. Gross profit came to DKK -271,767, and the net result was DKK -345,030.

Jan Evert Lilja leaves the board of ENKAM PHARMACEUTICALS ApSMay 24, 2017

As of May 24, 2017, Jan Evert Lilja has left the board of directors of ENKAM PHARMACEUTICALS ApS.

About ENKAM PHARMACEUTICALS ApS

ENKAM PHARMACEUTICALS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ENKAM PHARMACEUTICALS A/S. The company has 0 employees. In 2018, the company reported a gross profit of DKK -275,740 and a net result of DKK -293,665 compared with DKK -277,379 the year before. Equity amounted to DKK -1,179,474.

Other financial years